Kato Taku 加藤卓

… Alternative Names

加藤卓カトウタク

KATO Taku 加藤卓

Less

Researcher Number	50596202
Other IDs
Affiliation (Current)	2025: 藤田医科大学, 医学部, 准教授
Affiliation (based on the past Project Information) *help	2022 – 2024: 藤田医科大学, 医学部, 准教授 2021: 朝日大学, 歯学部, 准教授 2018: 岐阜大学, 医学部附属病院, 講師 2014 – 2015: 岐阜大学, 医学(系)研究科(研究院), 助教 2013: 岐阜大学, 医学(系)研究科(研究院), 医員
Review Section/Research Field	Principal Investigator Basic Section 56030:Urology-related / Urology Except Principal Investigator Basic Section 56030:Urology-related / Laboratory medicine
Keywords	Principal Investigator 去勢抵抗性前立腺癌 / 網羅的解析 / 細胞外小胞 / エクソソーム / 体液生検 / アンドロゲン除去療法 / RNA-sequencing / H19 / カバジタキセル / ドセタキセル … More / MDR1 / P糖タンパク / mi-RNA / エンザルタミド / Androgen Receptor / miRNA / Androgen receptor / 塩酸ゲムシタビン / 膀胱癌 … More Except Principal Investigator 細胞外小胞 / 前立腺癌 / エクソソーム / ARシグナル / 去勢抵抗性前立腺癌 / 遺伝子導入療法 / 遺伝子導入 / 遺伝子治療 / 癌免疫 / PSMA / PSA / リポソーム / パーフォリン / 癌 / 去勢・薬剤抵抗性 / 診断システム / 前立腺がん Less

Treatment selection based on diagnosis of castration-resistant prostate cancer heterogeneity through analysis of extracellular vesiclesPrincipal Investigator
- Principal Investigator
  
  加藤卓
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Fujita Health University
Novel therapeutic strategy for castration-resistant prostate cancer focusing on changes of AR signaling in extracellular vesicles
- Principal Investigator
  
  伊藤雅史
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Fujita Health University
Development of gene therapy using exosomes containing perforin expression vector
- Principal Investigator
  
  Mizutani Kosuke
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Social Medical Corporation Central Japan International Medical Center Research Support Center
  Gifu University
Diagnosis of drug sensitivity for castration-resistant prostate cancer using serum exosomesPrincipal Investigator
- Principal Investigator
  
  Kato Taku
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Fujita Health University
  Asahi University
Development of diagnostic system for prostate cancer by using exosomes
- Principal Investigator
  
  ITO MASAFUMI
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Laboratory medicine
- Research Institution
  Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology
前立腺癌患者血清エクソソーム中MDR1の測定Principal Investigator
- Principal Investigator
  
  加藤卓
- Project Period (FY)
  2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Gifu University
Identifying miRNAs associate for Gemcitabine resistance of bladder cancer and elucidating functional roles of their target genes.Principal Investigator
- Principal Investigator
  
  KATO Taku
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Urology
- Research Institution
  Gifu University

All 2023 2022 2021 2019 2017 2016 2015

All Journal Article Presentation

[Journal Article] H19 in serum extracellular vesicles reflects resistance to AR axis-targeted therapy among CRPC patients2023
- Author(s)
  Kato Taku、Kawakami Kyojiro、Mizutani Kosuke、Ando Tatsuya、Sakai Yasuhiro、Sakurai Kouhei、Toyota Shohei、Ehara Hidetoshi、Ito Hiroyasu、Ito Masafumi
- Journal Title
  
  Cancer Genomics - Proteomics
  
  Volume: 20 Issue: 5 Pages: 456-468
- DOI
  10.21873/cgp.20397
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K06987, KAKENHI-PROJECT-23K06860, KAKENHI-PROJECT-23K08790, KAKENHI-PROJECT-21K09437, KAKENHI-PROJECT-21K09862
[Journal Article] Gene therapy of prostate cancer using liposomes containing perforin expression vector driven by the promoter of prostate-specific antigen gene2022
- Author(s)
  Kosuke Mizutani, Kyojiro Kawakami, Yasunori Fujita, Taku Kato, Manabu Takai, Daiki Kato, Koji Iinuma, Takuya Koie, Masafumi Ito
- Journal Title
  
  Scientific Reports
  
  Volume: 12 Issue: 1 Pages: 1442-1442
- DOI
  10.1038/s41598-021-03324-6
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09340, KAKENHI-PROJECT-20H04136
[Journal Article] Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expression2017
- Author(s)
  Kameyama K, Horie K, Mizutani K, Kato T, Fujita Y, Kawakami K, Kojima T, Miyazaki T, Deguchi T, Ito M
- Journal Title
  
  Int J Oncol
  
  Volume: 50 Issue: 1 Pages: 75-84
- DOI
  10.3892/ijo.2016.3781
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16H05232
[Journal Article] Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer2017
- Author(s)
  Kyojiro Kawakami, Yasunori Fujita, Yoko Matsuda, Tomio Arai, Kengo Horie, Koji Kameyama, Taku Kato, Koichi Masunaga, Yutaka Kasuya, Masashi Tanaka, Kosuke Mizutani, Takashi Deguchi, Masafumi Ito
- Journal Title
  
  BMC Cancer
  
  Volume: 316 Issue: 1 Pages: 316-316
- DOI
  10.1186/s12885-017-3301-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25242062, KAKENHI-PROJECT-16K08754, KAKENHI-PROJECT-16K09412, KAKENHI-PROJECT-16H01872, KAKENHI-PROJECT-16H03267, KAKENHI-PROJECT-16H05232
[Journal Article] Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer.2015
- Author(s)
  Taku Kato, Kosuke Mizutani, Koji Kameyama, Yasunori Fujita, Yusuke Kanimoto, Hidetoshi Ehara, Hiroyasu Ito, Mitsuru Seishima, Takashi Deguchi, Masafumi Ito.
- Journal Title
  
  Urologic Oncology: Seminars and Original Investigations
  
  Volume: 33巻 Issue: 9 Pages: 385.e15-385.e20
- DOI
  10.1016/j.urolonc.2015.04.019
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15K10582
[Presentation] 血清中細胞外小胞内のH 1 9 は去勢抵抗性前立腺癌患者の内分泌療法に対する耐性の予測マーカーとなりうる2023
- Author(s)
  加藤卓、酒井康弘、伊藤弘康
- Organizer
  第70回日本臨床検査医学会学術集会
- Data Source
  KAKENHI-PROJECT-21K09437
[Presentation] Prostate cancer targeted therapy using PSA promoter-driven perforin expression vector encapsulated in liposomes conjugated with anti-PSMA antibody2022
- Author(s)
  Kosuke Mizutani, Kyojiro Kawakami, Yasunori Fujita, Taku Kato, Manabu Takai, Daiki Kato, Koji Iinuma, Takuya Koie and Masafumi Ito
- Organizer
  AACR Annual Meeting 2022
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K09340
[Presentation] 二重選択性を用いた抗体修飾プラスミド内包リポソームによる癌免疫治療法の開発2021
- Author(s)
  水谷晃輔、川上恭司郎、加藤卓、加藤大貴、高井学、飯沼光司、土屋朋大、伊藤雅史、古家琢也
- Organizer
  第71回日本泌尿器科学会中部総会
- Data Source
  KAKENHI-PROJECT-21K09340
[Presentation] Nivolumabを用いたELISAによる腎癌患者の血清中PD-1濃度の評価2019
- Author(s)
  水谷晃輔、堀江憲吾、加藤卓、中根慶太、川上恭司郎、藤田泰典、伊藤雅史
- Organizer
  第28回泌尿器科分子・細胞研究会
- Data Source
  KAKENHI-PROJECT-16H05232
[Presentation] Gamma-glutamyltransferase activity in exosomes as a marker for prostate and renal cell cancers.2017
- Author(s)
  Ito M, Kawakami K, Horie K, Fujita Y, Matsuda Y, Arai T, Kameyama K, Kato T, Masunaga K, Kasuya Y, Tanaka M, Deguchi T, Mizutani K.
- Organizer
  International Society for Extracellular Vesicles 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05232
[Presentation] エクソソーム上γ-グルタミルトランスフェラーゼ活性の前立腺がんと前立腺肥大の鑑別における有用性2016
- Author(s)
  川上恭司郎, 藤田泰典, 松田陽子, 新井冨生, 堀江憲吾, 亀山紘司, 加藤卓, 桝永浩一, 粕谷豊, 田中雅嗣, 水谷晃輔, 出口隆, 伊藤雅史
- Organizer
  第39回日本分子生物学会年会
- Place of Presentation
  パシフィコ横浜、横浜
- Year and Date
  2016-11-30
- Data Source
  KAKENHI-PROJECT-16H05232
[Presentation] Exosomal gamma-glutamyltransferase activity as a marker for prostate cancer2016
- Author(s)
  Ito M, Kawakami K, Fujita Y, Matsuda Y, Arai T, Horie K, Kameyama K, Kato T, Masunaga K, Kasuya Y, Tanaka M, Deguchi T, Mizutani K
- Organizer
  2016 ASEMV annual meeting
- Place of Presentation
  Asilomar Conference Center, Monterey, USA
- Year and Date
  2016-10-20
- Data Source
  KAKENHI-PROJECT-16H05232
[Presentation] エクソソーム上のγ-グルタミルトランスフェラーゼ活性は前立腺がんのマーカーとなる2016
- Author(s)
  川上恭司郎、藤田泰典、堀江憲吾、水谷晃輔、亀山紘司、加藤卓、粕谷豊、桝永浩一、松田陽子、出口隆、伊藤雅史
- Organizer
  第8回日本ＲＮＡｉ研究会・第3回日本細胞外小胞学会
- Place of Presentation
  グランドプリンスホテル広島、広島
- Year and Date
  2016-08-31
- Data Source
  KAKENHI-PROJECT-16H05232

1. Mizutani Kosuke (80397356)

# of Collaborated Projects: 6 results

# of Collaborated Products: 10 results
2. 川上恭司郎 (90589227)

# of Collaborated Projects: 5 results

# of Collaborated Products: 9 results
3. ITO MASAFUMI (80393114)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
4. 出口隆 (40163935)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
5. 亀山紘司 (50610424)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
6. 藤田泰典 (30515888)

# of Collaborated Projects: 2 results

# of Collaborated Products: 8 results
7. HORIE kengo

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
8. 田中雅嗣

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. 櫻井浩平

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
10. 酒井康弘

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Kato Taku 加藤 卓

加藤 卓 カトウ タク

KATO Taku 加藤 卓

Research Projects

Research Products

Co-Researchers

Treatment selection based on diagnosis of castration-resistant prostate cancer heterogeneity through analysis of extracellular vesiclesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Novel therapeutic strategy for castration-resistant prostate cancer focusing on changes of AR signaling in extracellular vesicles

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of gene therapy using exosomes containing perforin expression vector

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Diagnosis of drug sensitivity for castration-resistant prostate cancer using serum exosomesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of diagnostic system for prostate cancer by using exosomes

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

前立腺癌患者血清エクソソーム中MDR1の測定Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Identifying miRNAs associate for Gemcitabine resistance of bladder cancer and elucidating functional roles of their target genes.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] H19 in serum extracellular vesicles reflects resistance to AR axis-targeted therapy among CRPC patients2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Gene therapy of prostate cancer using liposomes containing perforin expression vector driven by the promoter of prostate-specific antigen gene2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expression2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer.2015

Author(s)

Journal Title

DOI

Data Source

[Presentation] 血清中細胞外小胞内のH 1 9 は去勢抵抗性前立腺癌患者の内分泌療法に対する耐性の予測マーカーとなりうる2023

Author(s)

Organizer

Data Source

[Presentation] Prostate cancer targeted therapy using PSA promoter-driven perforin expression vector encapsulated in liposomes conjugated with anti-PSMA antibody2022

Author(s)

Organizer

Kato Taku 加藤卓

加藤卓カトウタク

KATO Taku 加藤卓

[Presentation] 二重選択性を用いた抗体修飾プラスミド内包リポソームによる癌免疫治療法の開発2021